Tessera
Folgen

Jordy Cohen

@jordybc.bsky.social

Nephrologist, epidemiologist, methods nerd, climber, hypertension, MedEd, @ PennKidney https://dbei.med.upenn.edu/staff/jordana-cohen-md-msce/

481 Posts1384 Follower541 Folgt
Marwah Abdalla, MD MPH@marwahabdalla.bsky.social · 2mo ago

We have more ways to measure blood pressure than ever before but not necessarily more confidence in what those measurements mean. Our NHLBI workshop report in @jaccjournals.bsky.social chaired w/ @spjuraschek.bsky.social provides an implementation roadmap. www.sciencedirect.com/science/arti...

Blood Pressure Assessment Across the Lifespan: Improving Clinical Research and Clinical Practice: A National Heart, Lung, and Blood Institute Workshop Report

Hypertension is a modifiable risk factor for cardiovascular disease (CVD) and its prevalence is high in the United States and worldwide. Adequate char…

sciencedirect.com

John Giacona, PhD, PA-C@giaconajohn.bsky.social · 5mo ago

Excellent overview in The Washington Post on the systemic impact of sustained hypertension — from LVH to CKD and cognitive decline. Kudos to Drs. @drwanpen.bsky.social , John B, and @jordybc.bsky.social for evidence base insight. 🔗 www.washingtonpost.com/wellness/202... #Hypertension #Cardiology

What high blood pressure does to your body

Hypertension can affect your mind, heart, eyes and more, often without causing any obvious symptoms at all.

washingtonpost.com

Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · 9mo ago

Agree with your comments It mostly seems an extension/explanation of the ridiculous 2023 ESH guidelines (not to be confused with the superb 2024 ESC guidelines www.escardio.org/Guidelines/C...) A whole section to renal denervation 🤔 And such strong language against BP < 120

ESC Guidelines for the management of elevated blood pressure and hypertension

ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure for the management of ele...

escardio.org

Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · 10mo ago

There you go: www.ahajournals.org/doi/10.1161/... @ahascience.bsky.social statement from HT heavyweights

The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association | Hypertension

Over the past 3 decades, a substantial body of high-quality evidence has guided the diagnosis and management of elevated blood pressure (BP) in the outpatient setting. In contrast, there is a lack of ...

ahajournals.org

Penn Memory Center@pennmemorycenter.bsky.social · 11mo ago

High blood pressure often shows no symptoms, but raises risk of stroke, heart disease, kidney damage, and dementia. New American Heart Association guidelines: treat it early with diet & exercise. “If you catch it early, you can gain many more years of healthy life,” says Penn’s Dr. Jordana Cohen.

The silent killer increases your risk of stroke and dementia. Here's how to control it

New recommendations for early treatment of hypertension to prevent strokes, heart attacks and dementia come as an experimental medication is shown to lower blood pressure in hard-to-treat patients.

npr.org

Nephrology Journal Club@nephjc.bsky.social · 11mo ago

And that’s a wrap! In summary: screen carefully, stratify by risk, account for kidney health, and individualize therapy. For nephrology, the wins are undeniable: albuminuria testing is mainstream, CKD visibility is heightened, and aldosterone is on the radar. #NephJC

Nephrology Journal Club@nephjc.bsky.social · 11mo ago

T4l 1️⃣2️⃣No aggressive IV treatment for severe asymptomatic HTN - avoid acute inpatient lowering if no target-organ damage (COR III: Harm, LOE C-LD). 📝Treat the patient (situation) not the number for acute HTN during hospitalization. I have trouble convincing nocturnists of this. #NephJC

Cristina Popa@nephroseeker.medsky.social · 11mo ago

I would dare to say many people: if too young, if single pill combo is not enough to control BP. PA is more common than we are used to think. Usually, for us nephrologists is even harder to screen when pts are already on 4-5meds #nephjc www.nephjc.com/news/primary...

Undercover Aldosterone — NephJC

This week, we will discuss the origins of primary hyperaldosteronism in normotensive patients. Could this undetected anomaly be the cause of idiopathic hypertension and CKD?

nephjc.com

Nephrology Journal Club@nephjc.bsky.social · 11mo ago

⏰2 hours until #NephJC chat 🔍 Tonight we are talking about the 2025 ACC/AHA Blood Pressure guidelines! Eight years have passed since the last update. What’s different? What’s the same? Tonight we tackle it all!

2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Hypertension

AIM: The “2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” retires and replaces the “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.” METHODS: A comprehensive literature search was conducted from December 2023 to June 2024 to identify clinical studies, reviews, and other evidence performed on human subjects that were published since February 2015 in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to create a living, working document updating current knowledge in the field of high blood pressure aimed at all practicing primary care and specialty clinicians who manage patients with hypertension.

ahajournals.org

Nephrology Journal Club@nephjc.bsky.social · 11mo ago

Up next! New AHA/ACC hypertension guidelines #NephJC @ahascience.bsky.social @accintouch.bsky.social

2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation

AIM: The “2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” retires and replaces the “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.” METHODS: A comprehensive literature search was conducted from December 2023 to June 2024 to identify clinical studies, reviews, and other evidence performed on human subjects that were published since February 2015 in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to create a living, working document updating current knowledge in the field of high blood pressure aimed at all practicing primary care and specialty clinicians who manage patients with hypertension.

ahajournals.org

Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · 11mo ago

The era of ASIs is slowly dawning www.nejm.org/doi/full/10.... (Yeah spironolactone is just as good and cheaper) Disclosure: we recruited patients for this one

Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension | NEJM

Aldosterone dysregulation plays an important pathogenic role in hard-to-control hypertension. In several studies, baxdrostat, an aldosterone synthase inhibitor, reduced the seated systolic blood pr...

nejm.org